Geduld E E - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 133 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2014. The put-call ratio across all filers is 1.38 and the average weighting 0.2%.

Quarter-by-quarter ownership
Geduld E E ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q3 2015$168,000
-78.8%
12,500
-64.3%
0.16%
-67.9%
Q2 2015$791,000
+57.9%
35,0500.0%0.49%
+47.3%
Q1 2015$501,000
+72.8%
35,050
+16.6%
0.33%
+114.1%
Q4 2014$290,000
-29.3%
30,050
-33.3%
0.16%
-46.2%
Q3 2014$410,000
-17.0%
45,050
-10.0%
0.29%
-5.5%
Q2 2014$494,000
-46.8%
50,050
-31.5%
0.31%
-38.7%
Q1 2014$928,000
-4.7%
73,050
+12.4%
0.50%
+6.6%
Q4 2013$974,000
+35.7%
65,0000.0%0.47%
+7.3%
Q3 2013$718,000
+20.5%
65,000
-13.3%
0.44%
+3.5%
Q2 2013$596,00075,0000.42%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q4 2014
NameSharesValueWeighting ↓
Third Security, LLC 7,048,282$126,799,00027.23%
First Light Asset Management, LLC 1,630,591$29,334,0005.01%
SNYDER CAPITAL MANAGEMENT L P 3,393,057$61,041,0003.48%
Bellevue Group AG 7,663,956$137,874,0002.67%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 307,633$5,531,0002.52%
Lombard Odier Asset Management (Switzerland) SA 900,000$16,191,0002.17%
Elk Creek Partners, LLC 654,362$11,772,0002.02%
DOHENY ASSET MANAGEMENT /CA 127,110$2,254,0001.79%
Granite Investment Partners, LLC 1,277,438$22,981,0001.49%
Amia Capital LLP 69,409$1,249,0001.11%
View complete list of HALOZYME THERAPEUTICS INC shareholders